Lilly back in COVID-19 antibody game with $720 million deal with U.S. for omicron-busting hopeful kdunleavy Fri, 02/11/2022 […]
Fierce Pharma Asia—Lilly, Innovent’s PD-1 saga; Biogen, Eisai’s Aduhelm rebuttal; Surprise FDA foreign inspections? aliu Fri, 02/11/2022 – […]
AbbVie runs first Qulipta TV ad spots as it focuses on what you ‘can control inside’ badams Fri, […]
A large-scale study has found that simulation-based surgical training produced an increase of surgeons’ skills for more complex […]
The goal of the cluster project M3Infekt, initiated by the Fraunhofer-Gesellschaft, was to develop the technical basis for […]
BA.1(B.1.1.529.1)The original SARS-CoV-2 omicron variant is B.1.1.529.1, the version that most people think of when omicron is referred […]
In August 2020, Russian president Vladimir Putin announced that the Ministry of Health had approved use of Sputnik […]
Updated Date: Thu, 03 Feb 2022 00:00:00 EST
Updated Date: Thu, 03 Feb 2022 00:00:00 EST
Updated Date: Thu, 03 Feb 2022 00:00:00 EST